177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Study sponsor: Radiopharm Theranostics, Ltd · RADX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-12Estimated
Enrollment · participants61Estimated
Source updated2026-10-01Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.